Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 522 for “"osteosarcoma"”.

  1. Tratamiento actual del osteosarcoma

    … aplicados a los enfermos afectos de osteosarcoma. Planteamiento del problema se realizo un estudio general sobre el osteosarcoma con una revisión bibliográfica de todos los aspectos clínico-patológicos, así como de los diversos tratamientos de quimioterapia y cirugía, desde las …

    sevilla Repository record for Tratamiento actual del osteosarcoma (opens in a new tab)

  2. Purinergic signalling in osteosarcoma

    Osteosarcoma (OS) is the most common type of primary bone cancer affecting adolescents and children attributed to rapid bone growth and turnover, it is a rare incurable and often fatal disease. Current treatments include standard chemotherapy, limb salvage surgery or amputation. Survival statistics …

    whiterose Download PDF for Purinergic signalling in osteosarcoma (opens in a new tab)

  3. Uncovering Mechanisms of Osteosarcoma Metastasis

    Osteosarcoma (OS) is the most common primary malignant bone tumor, with metastatic disease responsible for most treatment failure and patient death. A better understanding of the metastatic disease state is needed to improve patient survival. The studies presented here explore a variety of …

    umn Repository record for Uncovering Mechanisms of Osteosarcoma Metastasis (opens in a new tab)

  4. Molecular Mechanisms Governing Osteosarcoma Pulmonary Metastasis

    Osteosarcoma (OS) is a bone cancer that commonly metastasizes to the lung. Despite advances in the development of targeted therapies for treating solid malignancies, broad-acting chemotherapies remain the first line of treatment for OS. In assaying the efficacy of approved therapeutics for non-OS …

    usf Repository record for Molecular Mechanisms Governing Osteosarcoma Pulmonary Metastasis (opens in a new tab)

  5. Characterization of Erbb4 Expression In Osteosarcoma

    … in studies characterizing ERBB4 expression in osteosarcoma, indicating that ERBB4 may be cleaved to enhance malignant behavior in osteosarcoma. ERBB4 protein was significantly up-regulated from monolayer to sphere cultures in osteosarcoma, leading to the hypothesis that there would be an …

    uthsc Repository record for Characterization of Erbb4 Expression In Osteosarcoma (opens in a new tab)

  6. Improving Nk Cell Therapy For Osteosarcoma

    <p>Osteosarcoma (OS) is the most common primary bone tumor. Despite new treatment options, 5-year survival for metastatic OS has remained at only 30% for the last 30 years. Adoptive transfer of Natural Killer (NK) cells holds promise for a new, non-toxic therapy for OS. NK cells are part of the …

    uthsc Repository record for Improving Nk Cell Therapy For Osteosarcoma (opens in a new tab)

  7. Energy Metabolism in Canine Appendicular Osteosarcoma

    … cancer initiation and metastasis. Appendicular osteosarcoma (OS) is an aggressive bone tumour of mesenchymal origin in domestic dogs, presenting a naturally occurring model for translational studies in human OS. In this thesis, it is hypothesized that energy metabolism drives chemoresistance in …

    guelph Repository record for Energy Metabolism in Canine Appendicular Osteosarcoma (opens in a new tab)

  8. Developing radioimmunotherapy for osteosarcoma using comparative oncology

    Osteosarcoma (OS) is one of the most common primary malignant bone cancer in children wherein the mortality rate within 5 years is 30% and patients suffer from bone pain, limited or loss of limb function, or fatigue. In addition, OS is one of the most widespread cancers in companion dogs, …

    sask Repository record for Developing radioimmunotherapy for osteosarcoma using comparative oncology (opens in a new tab)

  9. Targeted Biological and Cellular Immunotherapies for Osteosarcoma

    Osteosarcoma (OSA) is the most common cancer of the bone and third most common cancer diagnosed in children and adolescent. The five-year survival rate for OSA patients approaches 70%; however, this rate drops to less than 30% with metastatic disease. There have been no changes in treatment options …

    umn Repository record for Targeted Biological and Cellular Immunotherapies for Osteosarcoma (opens in a new tab)

  10. Immunomodulation in Osteosarcoma: From Therapy to Diagnostics

    Osteosarcoma (OS) is a rare pediatric bone malignancy. Those who develop advanced disease, often in the form of metastasis to the lung, experience poor five-year survival rates near approximately 25%. Considering minimal-to-no therapeutic breakthroughs have occurred for treatment of this disease …

    wvu Repository record for Immunomodulation in Osteosarcoma: From Therapy to Diagnostics (opens in a new tab)

  11. Therapeutic Targeting of BET Proteins in Osteosarcoma

    Osteosarcoma (OS) is an aggressive bone cancer in pediatric, adolescent, and young adult patients with an exceedingly poor prognosis. An area of therapeutic opportunity is that OS exhibits increased oncogenic replication stress (RS), augmenting genome instability and tumor progression. Exploiting …

    iupui Repository record for Therapeutic Targeting of BET Proteins in Osteosarcoma (opens in a new tab)

  12. The role of autophagy in canine osteosarcoma

    Canine osteosarcoma (OS) is a primary tumour in the bone and is mesenchymal in origin. The common sites affected are the metaphyseal regions of long bones, particularly the front limbs of dogs. Osteosarcoma in dogs shares many biological and clinical resemblances in humans with molecular and …

    middlesex

  13. Prediction of Outcome in Canine Appendicular Osteosarcoma

    Appendicular osteosarcoma is the most common 1° bone cancer of dogs. Pulmonary metastasis leads to mortality in most cases and chemoresistance is a common sequel. Reliable prognostic tools are lacking, and the standard of care for curative intent has not significantly changed in decades. To improve …

    guelph Repository record for Prediction of Outcome in Canine Appendicular Osteosarcoma (opens in a new tab)

  14. HSP70 Inhibition in Canine Osteosarcoma Cell Lines

    Osteosarcoma (OSA) is the most common primary bone cancer in canines. Despite the ability of chemotherapy treatment to prolong survival, canine patients continue to have a poor long term prognosis. Heat shock proteins (HSPs) typically function as molecular chaperones. Under stressful conditions, …

    guelph Repository record for HSP70 Inhibition in Canine Osteosarcoma Cell Lines (opens in a new tab)

  15. Molecular Determinants of Malignancy in Canine Osteosarcoma

    … (IGF2) retrospectively in a population of canine osteosarcoma patients. Furthermore, it describes the derivation and preliminary characterization of canine osteosarcoma primary cell cultures and the use of these cells to assess the effects of PRKAR1A expression on sensitivity to chemotherapeutic …

    guelph Repository record for Molecular Determinants of Malignancy in Canine Osteosarcoma (opens in a new tab)

  16. Genomic Analysis of Canine Appendicular Osteosarcoma Metastases

    … and metastatic samples of canine appendicular osteosarcoma that were preserved by either formalin fixation or freezing. The frozen samples were analyzed for copy number aberrations, RNA expression, and somatic variants, using arrayCGH, RNA microarrays, and DNA sequencing data. Comparison of DNA …

    guelph Repository record for Genomic Analysis of Canine Appendicular Osteosarcoma Metastases (opens in a new tab)

Page 1 of 27